Proceedings of the National Academy of Sciences · 1991 · 269 citations · 35 references
MedicineCancer BiologyOncologyGene ExpressionMetastasisSignal TransductionCancer Cell SignalingColorectal CancerGrowth Factor Receptor OncogenesGrowth Factor SignalingOncogenic Signaling PathwaysDifferential Transcript ExpressionEpidermal Growth Factor Receptor SignalingGrowth Factor Autocrine SignalingGrowth Factor Receptor ActivationGrowth Factors
Amphiregulin (AR) and cripto are proteins that are structurally related to epidermal growth factor (EGF) and transforming growth factor alpha (TGF-alpha). AR is also functionally related to this family of growth regulatory molecules and is able to bind and activate the 170-kDa EGF receptor (EGFR). Human EGFR-3 (HER3)/ERBB3 is a recently identified protein related to the EGFR that is widely expressed in breast carcinomas and is a candidate receptor for EGF-like growth factors. Differential expression of these putative ligands and receptors in transformed cells suggests that they may function in an autocrine manner to regulate tumor cell growth. Specific mRNA transcripts for TGF-alpha [4.8 kilobases (kb)], AR (1.4 kb), cripto (2.2 kb), and HER3 (6.2 kb) were expressed in a majority of human colon cancer cell lines. HER3 mRNA was detected in 55% of primary or metastatic human colorectal carcinomas but in only 22% of normal colon mucosa and 32% of normal liver samples. In contrast, cripto and AR mRNA were expressed in 60-70% of primary or metastatic human colorectal cancers but in only 2-7% of normal human colonic mucosa. Immunostaining also detected AR protein in primary and metastatic colorectal tumors but not in normal colon or uninvolved liver. These findings suggest that cripto and AR may be useful markers to discriminate between normal and malignant colonic epithelium and may provide a selective growth advantage for colorectal carcinomas.
35
Mutations in the p53 gene occur in diverse human tumour types
Janice Nigro, Suzanne J. Baker, Antonette C. Preisinger et al. · Nature · 1989 · 2.8K citations · Full text
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
Suzanne J. Baker, Eric R. Fearon, Janice Nigro et al. · Science · 1989 · 2.1K citations
Life Sciences, Genetics, Oncology +16
Prevalence of ras gene mutations in human colorectal cancers
Johannes L. Bos, Eric R. Fearon, Stanley R. Hamilton et al. · Nature · 1987 · 1.9K citations
Identification of a Chromosome 18q Gene that Is Altered in Colorectal Cancers
Eric R. Fearon, Kathleen R. Cho, Janice Nigro et al. · Science · 1990 · 1.7K citations
Life Sciences, Genetics, Oncology +17